ketamine for depression
k

Johnson & Johnson’s $1.7 Billion Drug Success Signals Growth in Psychedelic Medicine Market

Johnson & Johnson’s Spravato, a nasal spray derived from ketamine, has reached blockbuster status with annual sales exceeding $1 billion. Approved in 2019 for...

Popular

Performance Analysis of Singapore’s Largest IPOs of 2025

Singapore's initial public offering (IPO) market in 2025 has...

Fed Governor Waller Says Interest Rate Increases Are Possible

Federal Reserve Governor Christopher Waller indicated that the central...

NATO Allies Express Concern Over Trump’s Shifting Stance on US Troop Presence in Europe

NATO allies are expressing concern and confusion following recent...

Germany Becomes Top Destination for Jews Emigrating from Israel

An increasing number of Jewish Israelis are choosing Germany,...
spot_imgspot_imgspot_img
spot_imgspot_imgspot_imgspot_img